Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8525456rdf:typepubmed:Citationlld:pubmed
pubmed-article:8525456lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:8525456lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8525456lifeskim:mentionsumls-concept:C0082341lld:lifeskim
pubmed-article:8525456lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:8525456lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:8525456lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8525456pubmed:issue1lld:pubmed
pubmed-article:8525456pubmed:dateCreated1996-1-19lld:pubmed
pubmed-article:8525456pubmed:abstractTextWe stably expressed a rat D3 receptor cDNA in C6 glioma cells (C6-D3 cells), quantifying receptor expression with the radioligands [125I]epidepride (KD = 0.1 nM) and [3H]spiperone (KD = 0.7 nM). As reported previously for D2 receptors, quinpirole induced a 9-16% increase in the rate of extracellular acidification by C6-D3 cells. The acidification was inhibited by epidepride and by the Na+/H+ antiporter inhibitors, amiloride and methylisobutylamiloride, but pertussis toxin treatment had no effect on quinpirole-induced extracellular acidification. These data suggest that D3 receptor stimulation of Na+/H+ exchange in C6 glioma cells is not mediated by the pertussis toxin-sensitive G proteins, Gi or G(o). Overnight treatment of C6-D3 cells with N-propylnorapomorphine, dopamine, or quinpirole resulted in large concentration-dependent increases (up to 500%) in the density of D3 receptors on membranes prepared from the cells. Antagonists had smaller, variable effects on the density of D3 receptors in C6-D3 cells, except for domperidone, which significantly increased the density of D3 receptors. Treatment with pertussis toxin had no effect on the agonist-induced receptor up-regulation, indicating that an interaction with pertussis toxin-sensitive G proteins was not required. Densitometry analysis of Northern blots of RNA prepared from C6-D3 cells showed no significant N-propylnorapomorphine-induced increase in D3 receptor message. Treatment with cycloheximide, however, completely prevented receptor up-regulation by N-propylnorapomorphine. Pretreatment of C6-D2 cells with 10 microM DA resulted in a substantial heterologous sensitization, in which isoproterenol-stimulated adenylyl cyclase activity was enhanced more than twofold.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8525456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8525456pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8525456pubmed:languageenglld:pubmed
pubmed-article:8525456pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8525456pubmed:citationSubsetIMlld:pubmed
pubmed-article:8525456pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8525456pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8525456pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8525456pubmed:statusMEDLINElld:pubmed
pubmed-article:8525456pubmed:monthSeplld:pubmed
pubmed-article:8525456pubmed:issn0887-4476lld:pubmed
pubmed-article:8525456pubmed:authorpubmed-author:NeveR LRLlld:pubmed
pubmed-article:8525456pubmed:authorpubmed-author:CoxB ABAlld:pubmed
pubmed-article:8525456pubmed:authorpubmed-author:KozlowskiM...lld:pubmed
pubmed-article:8525456pubmed:authorpubmed-author:NeveK AKAlld:pubmed
pubmed-article:8525456pubmed:authorpubmed-author:RosserM PMPlld:pubmed
pubmed-article:8525456pubmed:authorpubmed-author:DuweK MKMlld:pubmed
pubmed-article:8525456pubmed:issnTypePrintlld:pubmed
pubmed-article:8525456pubmed:volume21lld:pubmed
pubmed-article:8525456pubmed:ownerNLMlld:pubmed
pubmed-article:8525456pubmed:authorsCompleteYlld:pubmed
pubmed-article:8525456pubmed:pagination1-9lld:pubmed
pubmed-article:8525456pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:meshHeadingpubmed-meshheading:8525456-...lld:pubmed
pubmed-article:8525456pubmed:year1995lld:pubmed
pubmed-article:8525456pubmed:articleTitleRegulation and functional characterization of a rat recombinant dopamine D3 receptor.lld:pubmed
pubmed-article:8525456pubmed:affiliationDepartment of Psychiatry, Oregon Health Sciences University, Portland 97201, USA.lld:pubmed
pubmed-article:8525456pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8525456pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8525456pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8525456pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8525456lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8525456lld:pubmed